MetaCap

Tonix Pharmaceuticals Statistics

NASDAQ: TNXPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.38-0.17 (-6.67%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Tonix Pharmaceuticals by the numbers

Tonix Pharmaceuticals has a market capitalization of $46.2 million based on 19.43M shares outstanding. With trailing EPS of $-12.39, Tonix Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 64.6% below its 50-day average and 79.2% below its 200-day average.

Average daily trading volume is 838.83K shares, or about $2.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TNXP valuation vs. peer median

TNXP compared with the median of 8 peer companies
MetricTNXPPeer medianDifference
Market cap$46.25M$46.10M+0%
Avg. volume838.83K671.88K+25%

Peer median across 8 companies: MIST, HOWL, RNXT, VRCA, NMAD, APLM, ONCY, QUCY.

Valuation

Market cap
$46.25M
Price / sales (latest FY)
3.53
EPS (TTM)
$-12.39

Price and trading

Previous close
2.55
Open
2.56
Day range
2.30 – 2.63
52-week range
2.30 – 20.56
52-week change
-85.22%
Beta
—
Volume
1.26M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
46.25M
Forward Pe
-0.34
Eps
-12.39
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
20.56
Week52 Low
2.30
Avg Volume
838.83K
Shares Outstanding
19.43M
Ma50
6.72
Ma200
11.45
Earnings Date
Nov 9, 2026
Pct From52w High
-88.42%
Pct From52w Low
3.48%

Related